Clinical Research Services - Experience

Experience

Reliance Life Sciences has designed, planned and conducted clinical research in all phases of product development.

If there is a specific type of study, therapeutic indication or special patient population that you are interested in that is not listed below, please email at ClinicalResearch.Enquiry@relbio.com for more information.

Pre-clinical Experience:

  • 14 days toxicology studies
  • 28 days toxicology studies
  • 90 days toxicology studies
  • 180 days toxicology studies
  • Genotoxicity studies
  • Acute Study
  • Ames
  • MNT
  • Skin Sensitization
  • Safety Handler studies
  • Medical device testing as per ISO 10993

Phase I & BA/BE Experience:

  • Pilot studies
  • Pivotal Studies
  • Two-stage design studies
  • Steady State studies
  • Drug-drug interaction studies
  • Food-drug interaction studies
  • Special population studies
  • Patient BE studies
  • Pharmacokinetic & Pharmacodynamic studies in biosimilars
  • Human mass balance studies
  • Cardiac safety studies (TQTc)
  • Skin blanching studies
  • Proof of Concept studies
  • Single Ascending Dose (SAD) studies
  • Multiple Ascending Dose (MAD) studies

Phase II – IV Therapeutic Experience:

  • Acute Medical Illness
  • Cardiovascular
  • Central Nervous System
  • Circulatory System
  • Dermatology
  • Endocrinology
  • Gastroenterology
  • Gynecology
  • Hematology
  • Immune System
  • Infectious Diseases
  • Medical Devices
  • Musculoskeletal
  • Nephrology
  • Oncology
  • Ophthalmology
  • Orthopedic
  • Psychiatry
  • Respiratory
  • Surgery